Olawaiye, A., Gladieff, L., Gilbert, L., Kim, J., Scaranti, M., Salutari, V., Hopp, E., Mileshkin, L. R., Devaux, A., McCollum, M., Oaknin, A., Leiser, A. L., Colombo, N., Clamp, A. R., Balazs, B., Scandurra, G., Kaczmarek, E., Pashova, H. I., Pai, S. G., Lorusso, D. (2025). ROSELLA: A phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in patients with platinum-resistant ovarian cancer (GOG-3073, ENGOT-ov72).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba5507